A range of GLP-1 weight loss drugs are currently on the market. What are they, what do they do, and where are they available?

and gastric inhibitory polypeptide drugs as of Wednesday, Jan. 1. The drugs can be used to prevent diabetes and to treat insulin resistance, metabolic syndrome or morbid obesity, according to a ...

Gut hormones that influence satiety, such as peptide YY (PYY ... the role of gut hormones in appetite change after Roux-en-Y gastric bypass. Le Roux et al. measured fasting and postprandial ...

“We are extremely excited to announce our second internal peptide-RI clinical development candidate, PD-29875, targeting CLDN18.2 for the potential diagnosis and treatment of gastric ...